Rödström, Karin E. J.
Kiper, Aytuğ K. http://orcid.org/0000-0003-2850-2523
Zhang, Wei
Rinné, Susanne
Pike, Ashley C. W. http://orcid.org/0000-0001-9661-2607
Goldstein, Matthias
Conrad, Linus J.
Delbeck, Martina
Hahn, Michael G.
Meier, Heinrich
Platzk, Magdalena
Quigley, Andrew
Speedman, David
Shrestha, Leela
Mukhopadhyay, Shubhashish M. M. http://orcid.org/0000-0003-1430-5529
Burgess-Brown, Nicola A.
Tucker, Stephen J. http://orcid.org/0000-0001-8996-2000
Müller, Thomas
Decher, Niels
Carpenter, Elisabeth P. http://orcid.org/0000-0001-9138-2937
Article History
Received: 8 July 2019
Accepted: 12 March 2020
First Online: 29 April 2020
Competing interests
: M.D., M.G.H., H.M. and T.M. are listed as inventors on patent number WO2017097792A1, priority date 10 December 2018, entitled ‘2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of TASK-1 and TASK-3 channels, for the treatment of sleep-related breathing disorders’. N.D. is listed as an inventor on patent number EP18189182.1, priority date 15 August 2018, entitled ‘TASK-1 inhibitors for treatment of atrial arrhythmias’. The other authors declare no competing interests.